-
-
-
-
-
-
-
Cytokinetics (CYTK) July 100 and January 80 calls active, share price down 3.9%
-
-
-
-
-
-
-
Cytokinetics (CYTK) PT Raised to $106 at Truist Securities
-
-
-
-
-
-
-
Wells Fargo Starts Cytokinetics (CYTK) at Overweight
-
-
-
-
-
-
-
Cytokinetics (CYTK) PT Raised to $67 at BofA Securities
-
-
-
-
-
-
-
Barclays Assumes Cytokinetics (CYTK) at Overweight
-
-
-
-
-
-
-
Cytokinetics (CYTK) PT Raised to $95 at RBC Capital
-
-
-
-
-
-
-
Piper Sandler on Biotechnology: 'What Commercial Names to Own in 2026?'
-
451,573 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

